Citations

Clear

13603 citation(s) found for "_, _".

Faculty Utilization of X (Formerly: Twitter): What, Why, and How Many
Akhund, Ramsha , Lanka, Santh Prakash , Allahwasaya, Ashba , Saleeb, Andrew G. , Fazendin, Jessica , Saleeb, Andrew G , McLeod, Chandler , Gillis, Andrea , Chen, Herbert , Liu, Jessica

Mayo Clinic

The American Surgeon™ | October 24, 2025 | Volume: 92 | Issue: 4 | Pages: 1206-1213

10.1177/00031348251388955 | PMID 41133845 Get It

Introduction Social media platforms, particularly X (formerly Twitter), play an influential role in professional networking and information dissemination. This study aimed to examine X usage trends among faculty in a single department of surgery at a large academic institution. Methods Faculty X accounts were analyzed from January to June 2022. Metrics such as follower count, number of accounts followed, and post (formerly: tweets) types (original/quoted reposts) were studied. Themes of posts were categorized as personal, promotional, educational, or related to academic events/conferences. Associations between faculty rank, division, gender, and post metrics were explored using Mann-Whitney U and Kruskal-Wallis tests. Results Of 133 faculty members, 53 (39.85%) had X accounts, with 3 excluded due to privacy settings. A total of 3476 posts were analyzed, averaging 0-34 posts/month per faculty. Categories included professional (63%, n = 2174), educational (19%, n = 653), and personal (13%, n = 436). No significant associations were found between faculty gender/division and posting rates. However, faculty rank correlated significantly with primary post categories ( P < 0.01). Associate professors, and professors posted more about academic events (2% and 1%) than instructors or assistant professors (1%). The most followed faculty actively promoted colleagues’ work through reposting. Conclusion Less than half the faculty in a single department of surgery engaged with X. Those active predominantly used it for promotion, followed by education and personal use. Adoption remains limited, highlighting opportunities for growth in utilizing X for academic dissemination.
Ethnocentric perceptions, impacts and influences of problematic alcohol use in a global community sample: a mixed-methods study
Butterfield, Richard , Sardana, Srishti , Mukkatira, Amrit, Rai, Sharada , Appachu, Kariappa, Kundranda, Roshni, Michlig, Georgia J. , Chakkera, Harini A , Chakkera, Harini A. , Unnikrishnan, Bhaskaran

Mayo Clinic

BMJ Public Health | October 24, 2025 | Volume: 3 | Issue: 2 | Pages: e002385

10.1136/bmjph-2024-002385 | PMID 41158616 Get It

Introduction Problematic alcohol use negatively impacts individuals, families and communities. While perceptions regarding alcohol use are likely vital to mitigating problematic alcohol use at the population level, little is known. Perceptions that demarcate normative versus problematic use may be relevant for interventions in communities with normative alcohol use. Our study explores ethnocentric perceptions of alcohol use in a community where alcohol use is historically integrated into its social fabric. Methods Mixed-methods study design using a culturally curated online survey with closed and open-ended responses assessed perceptions regarding alcohol use. Participants were members of the Kodava community: an affluent ethno-linguistic community in Southern India with an international presence. For Kodavas, alcohol consumption is normative and socially sanctioned. We studied perceptions of alcohol use among family members, including factors influencing its use and the impact of problematic alcohol drinking on immediate and extended family in three domains: health, finances and relationships. Results Of 711 total respondents, a small minority of 11.4% (n=81) stated that at least one immediate family member experienced negative impacts of alcohol use. Among respondents who reported on their extended family (n=639), 52.1% (n=333) endorsed at least one member experienced negative impacts. The integration of quantitative and qualitative data elucidates negative impacts of alcohol use within and at the intersections of health, relationships and finances. Conclusions First study to employ social media (WhatsApp) to survey a globally dispersed ethnic community on alcohol use impacts among family members. Interventions tailored to these perceptions, in culturally embedded communities, may improve outcomes. The framework and approach of this study can be replicated globally.
3498 Non-invasive neuromodulation for the treatment of drug-resistant epilepsy: systematic review and meta-analysis investigating efficacy, safety, and optimal stimulation parameters
Premaratne, Sayumi , Hamer, Ryan P. , O’Brien, Terry, Zoghi, Maryam , Antonic‐Baker, Ana , Chen, Zhibin ZC , Chen, Leo , Major, Brendan P. , Thomas, Elizabeth H. X. , Kwan, Patrick , O’Brien, Terry, Lundstrom, Brian N. , Simpson, Hugh D.

Mayo Clinic

Poster Abstracts | October 24, 2025 | Volume: No volume available | Issue: No issue available | Pages: A27.2-A27

10.1136/bmjno-2025-anzan.72 Get It

Beyond Hemoglobin A 1 c —Hypoglycemia, Glycemic Patterns, and Risk of Diabetic Retinopathy
Giacalone, Joseph C. , Barkmeier, Andrew J.

Mayo Clinic

JAMA Ophthalmology | October 23, 2025 | Volume: 143 | Issue: 12 | Pages: 997

10.1001/jamaophthalmol.2025.3933 | PMID 41129135 Get It

Self-harm in children and young people who die by suicide: UK-wide consecutive case series: commentary, McKean et al
McKean, Alastair J. , Bommersbach, Tanner J. , Bostwick, John , McKean, Alastair J S , Bostwick, J Michael

Mayo Clinic

The British Journal of Psychiatry | October 23, 2025 | Volume: 228 | Issue: 1 | Pages: 81-82

10.1192/bjp.2025.10449 | PMID 41128671 Get It

Final 60-Month Efficacy, Safety, and Kidney Stone Outcomes of a Phase 3 Trial of Lumasiran for Primary Hyperoxaluria Type 1 in Infants and Young Children
Sas, David J. , Michael, Mini , Frishberg, Yaacov, Ben‐Shalom, Efrat , Shasha‐Lavsky, Hadas , Sellier-Leclerc, A.L., Hogan, Julien, Du, W. J. , Murphy, Michael Desmond, Kaspar, Cristin , Magen, Daniella , Hayes, Wesley Nathan , Sellier‐Leclerc, Anne‐Laure , Hogan, Julien , Du, Weiming

Mayo Clinic

Journal of the American Society of Nephrology | October 23, 2025 | Volume: 36 | Issue: 10S | Pages: No page available

10.1681/asn.2025v7er7rv3 Get It

Autosomal Recessive PKD: Not Just for Kids, Long-Term Outcomes in Early vs. Late-Onset Disease
Borghol, Abdul Hamid , Potretzke, Theodora A. , Gregory, Adriana , Yang, Hana , Smith, Byron H. , Elbarougy, Doaa E. , Thompson, Whitney S. , Dahl, Neera K. , Torres, Vicente E. , Gitomer, Berenice Y , Ong, Albert , Chebib, Fouad T. , Harris, Peter C. , Hanna, Christian

Mayo Clinic

Journal of the American Society of Nephrology | October 23, 2025 | Volume: 36 | Issue: 10S | Pages: No page available

10.1681/asn.2025bf6aaxjq Get It

Artificial Intelligence in ADPKD: Transforming Diagnosis, Risk Stratification, and Therapeutic Interventions
Cheungpasitporn, Wisit, Pour, Amir Abdi, Ebrahimi, Niloufar , Cheungpasitporn, Wisit , Abdipour, Amir

Mayo Clinic

Journal of the American Society of Nephrology | October 23, 2025 | Volume: 36 | Issue: 10S | Pages: No page available

10.1681/asn.2025kyv7z71t Get It

Developing the Novel Sorbent ZO as an Oral Gut Oxalate Binder: Therapeutic Implications for Hyperoxaluria, Hyperoxalemia, and Related Disorders
Abdelhalim, Khalid A. , Wang, Yanzhe , Namagerdi, Asadoor Amirkhani, Mburu, David A, Bai, Karoona , Ali, Bilal , Elsanousi, Nusiba, Ash, Stephen R. , Alfuraiji, Narjes , Mburu, David A, Carr, David John , Hassan, Hatim

Mayo Clinic

Journal of the American Society of Nephrology | October 23, 2025 | Volume: 36 | Issue: 10S | Pages: No page available

10.1681/asn.2025x52k9392 Get It

Treatment of Children and Adults With X-Linked Hypophosphatemia With Calcitriol Alone: A Prospective, Open-Label Study
Jordan, Mackenzie, Gehman, Sarah, Rudolph, Sara , Jüppner, Harald , Thacher, Thomas, Lee, Hang , Gee, Michael S. , Pierce, Theodore T. , Ceglia, Lisa, Bouxsein, Mary , Demay, Marie B. , Liu, Eva S. , Lee, Hang , Ceglia, Lisa , Liu, Eva S , Mitchell, Deborah M. , Misra, Madhusmita , Thacher, Thomas, Gee, Michael Stanley

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 23, 2025 | Volume: 111 | Issue: 4 | Pages: e1037-e1049

10.1210/clinem/dgaf585 | PMID 41137448 Get It

Abstract Context Preclinical studies demonstrate that treatment with calcitriol attenuates skeletal complications in mice with X-linked hypophosphatemia (XLH). Objective This work aimed to assess serum markers of mineral metabolism, nephrocalcinosis, skeletal microarchitecture, growth, and evidence of rickets following calcitriol monotherapy in children and adults with XLH. Methods A 1-year, prospective, single-arm, open-label study was conducted comparing baseline and 12-month outcomes. Participants were recruited from outpatient endocrinology clinics in the United States. Data were collected in a research unit. Eligible participants were aged 4 years or older, not pregnant, with baseline 25-hydroxyvitamin D of 20 ng/mL or greater and normal serum calcium. Participants were treated with calcitriol, with dose based on serum and urinary calcium concentrations, for 1 year. The primary end points were change in serum phosphate and nephrocalcinosis (all participants) and rickets severity score (children). Secondary end points included changes in additional markers of mineral metabolism, skeletal microarchitecture parameters via high-resolution peripheral quantitative computed tomography (all participants), and height z-scores (children). Results Serum phosphate did not change over 12 months of optimized calcitriol treatment. Rickets improved in 2 of 4 children with open epiphyses; height z-scores were unchanged. Nephrocalcinosis scores remained stable. Adults had increased cortical thickness at the radius diaphysis (P = .012). Serum alkaline phosphatase decreased in children (P = .021) and parathyroid hormone trended lower both in children (P = .065) and adults (P = .063). Four participants developed mild hypercalcemia and 2 developed hypercalciuria that resolved with calcitriol titration. Conclusion Calcitriol monotherapy is safe and well-tolerated in XLH, with modest benefits on laboratory indices of mineral metabolism and rickets.